Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiro Koh

Showing results (91-100 of 144) with videos related to

Pageof 15
Sort By:
Leukemia & Lymphoma|October 15, 2025
Genetic analysis of cell-free DNA in follicular lymphoma in comparison with tissue-derived DNAYoshikazu Hori, Hiroki Hosoi, Mitsuo Osuga, et al.
BMC Cancer|January 3, 2023
Afatinib plus osimertinib in the treatment of osimertinib-resistant non-small cell lung carcinoma: a phase I clinical trialSatoru Miura, Yasuhiro Koh, Koichi Azuma, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 20, 2012
Prognostic impact of circulating tumor cells in patients with small cell lung cancerTateaki Naito, Fumihiro Tanaka, Akira Ono, et al.
Cancer Medicine|January 31, 2020
Detection of AXL expression in circulating tumor cells of lung cancer patients using an automated microcavity array systemMio Ikeda, Yasuhiro Koh, Shunsuke Teraoka, et al.
Lung Cancer (Amsterdam, Netherlands)|November 22, 2019
Predictive impact of low-frequency pretreatment T790M mutation in patients with EGFR-mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitorsYoshiya Matsumoto, Kenji Sawa, Mitsuru Fukui, et al.
Cancer Science|August 2, 2019
Impact of tumor microenvironment on the efficacy of epidermal growth factor receptor-tyrosine kinase inhibitors in patients with EGFR-mutant non-small cell lung cancerYoshiya Matsumoto, Kenji Sawa, Mitsuru Fukui, et al.
The Journal of Biological Chemistry|April 26, 2013
The A128T resistance mutation reveals aberrant protein multimerization as the primary mechanism of action of allosteric HIV-1 integrase inhibitorsLei Feng, Amit Sharma, Alison Slaughter, et al.
The Journal of Biological Chemistry|March 23, 2012
Multimode, cooperative mechanism of action of allosteric HIV-1 integrase inhibitorsJacques J Kessl, Nivedita Jena, Yasuhiro Koh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 4, 2011
Expression of excision repair cross-complementation group 1, breast cancer susceptibility 1, and β III-tubulin in thymic epithelial tumorsKyoichi Kaira, Masakuni Serizawa, Yasuhiro Koh, et al.
Lung Cancer (Amsterdam, Netherlands)|March 25, 2014
Molecular profiling of small cell lung cancer in a Japanese cohortKazushige Wakuda, Hirotsugu Kenmotsu, Masakuni Serizawa, et al.
Pageof 15

Showing results (91-100 of 144) with videos related to

Sort By:
Pageof 15
Leukemia & Lymphoma|October 15, 2025
Genetic analysis of cell-free DNA in follicular lymphoma in comparison with tissue-derived DNAYoshikazu Hori, Hiroki Hosoi, Mitsuo Osuga, et al.
BMC Cancer|January 3, 2023
Afatinib plus osimertinib in the treatment of osimertinib-resistant non-small cell lung carcinoma: a phase I clinical trialSatoru Miura, Yasuhiro Koh, Koichi Azuma, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 20, 2012
Prognostic impact of circulating tumor cells in patients with small cell lung cancerTateaki Naito, Fumihiro Tanaka, Akira Ono, et al.
Cancer Medicine|January 31, 2020
Detection of AXL expression in circulating tumor cells of lung cancer patients using an automated microcavity array systemMio Ikeda, Yasuhiro Koh, Shunsuke Teraoka, et al.
Lung Cancer (Amsterdam, Netherlands)|November 22, 2019
Predictive impact of low-frequency pretreatment T790M mutation in patients with EGFR-mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitorsYoshiya Matsumoto, Kenji Sawa, Mitsuru Fukui, et al.
Cancer Science|August 2, 2019
Impact of tumor microenvironment on the efficacy of epidermal growth factor receptor-tyrosine kinase inhibitors in patients with EGFR-mutant non-small cell lung cancerYoshiya Matsumoto, Kenji Sawa, Mitsuru Fukui, et al.
The Journal of Biological Chemistry|April 26, 2013
The A128T resistance mutation reveals aberrant protein multimerization as the primary mechanism of action of allosteric HIV-1 integrase inhibitorsLei Feng, Amit Sharma, Alison Slaughter, et al.
The Journal of Biological Chemistry|March 23, 2012
Multimode, cooperative mechanism of action of allosteric HIV-1 integrase inhibitorsJacques J Kessl, Nivedita Jena, Yasuhiro Koh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 4, 2011
Expression of excision repair cross-complementation group 1, breast cancer susceptibility 1, and β III-tubulin in thymic epithelial tumorsKyoichi Kaira, Masakuni Serizawa, Yasuhiro Koh, et al.
Lung Cancer (Amsterdam, Netherlands)|March 25, 2014
Molecular profiling of small cell lung cancer in a Japanese cohortKazushige Wakuda, Hirotsugu Kenmotsu, Masakuni Serizawa, et al.
Pageof 15